Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
13.4 USD | -1.00% | -6.69% | +17.94% |
Apr. 30 | Alvotech to Manufacture Humira Biosimilar for Quallent Pharmaceuticals | MT |
Apr. 30 | Alvotech to Make Humira Biosimilar Adalimumab-ryvk for Quallent | MT |
Business Summary
Number of employees: 999
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biosimilar Medicines
100.0
%
| 83 | 100.0 % | 91 | 100.0 % | +10.12% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Europe
69.5
%
| 39 | 47.5 % | 64 | 69.5 % | +61.06% |
North America
20.0
%
| 31 | 37.1 % | 18 | 20.0 % | -40.53% |
Asia and Other
10.5
%
| 0 | 0.0 % | 10 | 10.5 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Vilhelm Wessman
CEO | Chief Executive Officer | 54 | 18-11-01 |
Joel Morales
DFI | Director of Finance/CFO | 46 | 20-01-31 |
Giedrius Zunda
CTO | Chief Tech/Sci/R&D Officer | - | 22-12-31 |
Chief Tech/Sci/R&D Officer | 50 | 19-09-30 | |
Faysal Kalmoua
COO | Chief Operating Officer | 48 | 20-05-31 |
Investor Relations Contact | - | 22-03-01 | |
Ming Li
PRN | Corporate Officer/Principal | 47 | - |
Anil Okay
PRN | Corporate Officer/Principal | 38 | - |
Helga Zharov
LAW | General Counsel | 57 | 20-04-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Linda McGoldrick
BRD | Director/Board Member | 69 | 22-06-15 |
Helga Zharov
LAW | General Counsel | 57 | 20-04-30 |
Vilhelm Wessman
CEO | Chief Executive Officer | 54 | 18-11-01 |
Tomas Ekman
BRD | Director/Board Member | 56 | 18-12-31 |
Richard Davies
BRD | Director/Board Member | 62 | 18-12-31 |
Árni Harðarson
BRD | Director/Board Member | 57 | 22-06-15 |
Lisa Graver
BRD | Director/Board Member | 53 | 22-06-15 |
Faysal Kalmoua
COO | Chief Operating Officer | 48 | 20-05-31 |
Ann Merchant
BRD | Director/Board Member | 59 | 22-06-15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 266,821,844 | 72,673,643 ( 27.24 %) | 0 | 27.24 % |
Company contact information
Sector
Sales per region
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+17.94% | 3.8B | |
+23.37% | 47.02B | |
+49.84% | 41.86B | |
-0.94% | 41.76B | |
-4.32% | 28.8B | |
+11.29% | 26.05B | |
-20.92% | 19.15B | |
+3.20% | 12.55B | |
-2.67% | 11.82B | |
+30.23% | 12.34B |
- Stock Market
- Equities
- ALVO Stock
- Company Alvotech